tiprankstipranks
Tempest Therapeutics (TPST)
NASDAQ:TPST

Tempest Therapeutics (TPST) Financial Statements

902 Followers

Tempest Therapeutics Financial Overview

Tempest Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.721; its P/E ratio is -1.29; Tempest Therapeutics is scheduled to report earnings on August 12, 2024, and the estimated EPS forecast is $-0.40. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -7.54M$ -6.41M$ -7.23M$ -7.29M-
EBITDA$ -7.45M$ -6.33M$ -7.14M$ -7.17M-
Net Income Common Stockholders$ -7.90M$ -6.79M$ -7.58M$ -7.64M-
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 32.30M$ 11.10M$ 17.60M$ 23.35M$ 31.20M
Total Assets$ 44.38M$ 23.99M$ 30.74M$ 37.33M$ 46.09M
Total Debt$ 20.37M$ 21.01M$ 21.48M$ 21.66M$ 22.11M
Net Debt$ -11.93M$ 9.91M$ 3.88M$ -1.69M$ -9.09M
Total Liabilities$ 23.75M$ 25.18M$ 25.73M$ 26.36M$ 27.98M
Stockholders Equity$ 20.63M$ -1.19M$ 5.01M$ 10.96M$ 18.11M
Cash Flow-
Free Cash Flow$ -7.35M$ -6.49M$ -6.51M$ -8.35M-
Operating Cash Flow$ -7.19M$ -6.49M$ -6.39M$ -8.30M-
Investing Cash Flow$ -168.00K-$ -117.00K$ -46.00K-
Financing Cash Flow$ 450.00K$ 21.00K$ 1.19M$ 44.00K-
Currency in USD

Tempest Therapeutics Earnings and Revenue History

Tempest Therapeutics Debt to Assets

Tempest Therapeutics Cash Flow

Tempest Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis